Increasing SARS-CoV-2 nucleic acid testing capacity during the COVID-19 epidemic in Beijing: experience from a general hospital

Under the ongoing COVID-19 prevention and control measures in China, increasing the laboratory severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid testing capacity has become the top priority. Since the COVID-19 outbreak in Xinfadi market in Beijing in June 2020, large-scale sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Zhao, Xiaotao, Yue, Zhihong, Bai, Xiaohui, Rao, Huiying, Han, Na, Wang, Tianbing, Wang, Hui, Jiang, Baoguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605315/
https://www.ncbi.nlm.nih.gov/pubmed/33054582
http://dx.doi.org/10.1080/22221751.2020.1837016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605315/
https://www.ncbi.nlm.nih.gov/pubmed/33054582
http://dx.doi.org/10.1080/22221751.2020.1837016

Ejemplares similares